MacroGenics
MGNX
#8495
Rank
A$0.31 B
Marketcap
A$4.93
Share price
1.15%
Change (1 day)
145.48%
Change (1 year)

Market capitalization of MacroGenics (MGNX)

Market cap: A$0.31 Billion

As of April 2026 MacroGenics has a market cap of A$0.31 Billion. This makes MacroGenics the world's 8495th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of MacroGenics from 2020 to 2026

End of year Market Cap

Year Marketcap Change
2026A$0.31 B106.21%
2025A$0.15 B-53.35%
2024A$0.32 B-62.79%
2023A$0.87 B44.49%
2022A$0.60 B-55.34%
2021A$1.35 B-18.83%
2020A$1.67 B

End of Day market cap according to different sources

On Apr 13th, 2026 the market cap of MacroGenics was reported to be:

A$0.30 Billion
by Nasdaq info icon info icon
A$0.30 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
A$217.57 B 69,291.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$1.177 T 375,325.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$264.53 B 84,267.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A$243.47 B 77,551.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$412.68 B 131,517.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$166.66 B 53,053.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
A$1.26 B 303.19%๐Ÿ‡บ๐Ÿ‡ธ USA